Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of the Nutraceutical "Hemofix" Safety and Effect on the Coagulation System

NCT01651468 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01651468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01651468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of the Nutraceutical "Hemofix" Safety and Effect on the Coagulation System
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Withdrawn
Start date
September 30, 2016
Completion date
December 31, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menorrhagia, von willebrand disease